HomeInsightsStock Comparison

Shilpa Medicare Ltd vs Smruthi Organics Ltd Stock Comparison

Shilpa Medicare Ltd vs Smruthi Organics Ltd Stock Comparison

Last Updated on: Jun 13, 2025

Key Highlights

  • The Latest Trading Price of Shilpa Medicare Ltd is ₹ 986.15 as of 13 Jun 15:30.
  • The P/E Ratio of Shilpa Medicare Ltd changed from 12.8 on March 2020 to 125.7 on March 2024 . This represents a CAGR of 57.92% over 5 yearsThe P/E Ratio of Smruthi Organics Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Shilpa Medicare Ltd changed from ₹ 1993 crore on March 2020 to ₹ 4004 crore on March 2024 . This represents a CAGR of 14.97% over 5 yearsThe Market Cap of Smruthi Organics Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Shilpa Medicare Ltd for the Mar '25 is ₹ 340.68 crore as compare to the Dec '24 revenue of ₹ 320.79 crore. This represent the growth of 6.2% The revenue of Smruthi Organics Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Shilpa Medicare Ltd for the Mar '25 is ₹ 58.56 crore as compare to the Dec '24 ebitda of ₹ 82.17 crore. This represent the decline of -28.73% The ebitda of Smruthi Organics Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Shilpa Medicare Ltd changed from ₹ 1.18 crore to ₹ 14.51 crore over 8 quarters. This represents a CAGR of 250.67% The net profit of Smruthi Organics Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Shilpa Medicare Ltd changed from 4.63 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Smruthi Organics Ltd changed from 13.56 % on March 2020 to 48.24 % on March 2025 . This represents a CAGR of 23.55% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Shilpa Medicare Ltd

  • Shilpa Medicare Limited (Formerly known as Shilpa Antibiotics Private Limited) was incorporated as a Private Limited Company on November 20, 1987.
  • The Company changed the status to Public Limited and the name of the Company was changed to Shilpa Antibiotics Limited in November, 1993 and later on, was changed to 'Shilpa Medicare Limited' on February 17, 2003. The Company has been promoted by Vishnukant C. Bhutada and his Associates and is engaged in manufacturing of API, Formulation and Development service.
  • The Company started its operations as API manufacturer way back in 1987 at Raichur, Karnataka.
  • It then started commercial production in November, 1989. The Company is one of the leading API and formulations manufacturers with strong capabilities in the therapeutic area of oncology.

About Smruthi Organics Ltd

  • Smruthi Organics Limited was incorporated in July, 1989 as a Private Limited Company and was subsequently converted into a Public Limited Company in February, 1995.
  • The Company was promoted by E Purushotham and Shankarrao R Myakal.
  • The Company is a manufacturer of Active Pharmaceutical Ingredient (API) products in the Anti - Diabetic, Anti - Hypertension and Anti - Infectives Therapeutic categories catering to both the Indian domestic as well as rest of the world (ROW) markets, with clients spanning across Asia, Americas, and Africa.
  • It has 2 manufacturing facilities in Solapur, India. The Company set up a plant at Solapur, Maharashtra, to manufacture bulk drugs like diloxanide furoate (inst. cap. : 24 tpa) and sulphadiazine (inst. cap. : 36 tpa).
  • It expanded its activities and product range in 1993-94 by manufacturing metronidazole benzoate, tinidazole, paracetamol and norfloxacin.

Shilpa Medicare Ltd News Hub

News

Board of Shilpa Medicare recommends final dividend

Shilpa Medicare announced that the Board of Directors of the Company at its meeting held o...

Read more

27 May 2025 11:37

News

Shilpa Medicare slides after Q4 PAT drop 41% YoY to Rs 15-cr

Profit before exceptional items and tax stood at Rs 43.35 crore in Q4 FY25, up 100.88% fro...

Read more

27 May 2025 16:01

News

Shilpa Medicare Ltd leads gainers in 'A' group

Netweb Technologies India Ltd, Linde India Ltd, Vaibhav Global Ltd and ITD Cementation Ind...

Read more

26 May 2025 12:00

News

Shilpa Medicare zooms as arm partners with Orion Corporation

Under this strategic agreement, Orion Corporation will serve as the exclusive partner for ...

Read more

23 May 2025 15:37

News

Shilpa Medicare to conduct board meeting

Shilpa Medicare will hold a meeting of the Board of Directors of the Company on 26 May 202...

Read more

19 May 2025 16:26

News

Shilpa Medicare gains after arm receives EIR from USFDA for unit-1 facility

In an exchange filing, the company stated that the USFDA has classified the inspection out...

Read more

15 May 2025 09:56

Smruthi Organics Ltd News Hub

News

Board of Smruthi Organics recommends final dividend

Smruthi Organics announced that the Board of Directors of the Company at its meeting held ...

Read more

05 May 2025 13:58

News

Smruthi Organics AGM scheduled

Smruthi Organics announced that the 36th Annual General Meeting(AGM) of the company will b...

Read more

05 May 2025 13:58

News

Smruthi Organics announces board meeting date

Smruthi Organics will hold a meeting of the Board of Directors of the Company on 5 May 202...

Read more

16 Apr 2025 21:01

News

Smruthi Organics to table results

Smruthi Organics will hold a meeting of the Board of Directors of the Company on 4 Februar...

Read more

23 Jan 2025 14:47

News

Smruthi Organics to table results

Smruthi Organics will hold a meeting of the Board of Directors of the Company on 14 Novemb...

Read more

07 Nov 2024 14:19

News

Smruthi Organics schedules AGM

Smruthi Organics announced that the 35th Annual General Meeting (AGM) of the company will ...

Read more

29 Jul 2024 17:07

SWOT Analysis Of Shilpa Medicare Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Smruthi Organics Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Shilpa Medicare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Smruthi Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Shilpa Medicare Ltd and Smruthi Organics Ltd

Which company has a larger market capitalization, Shilpa Medicare Ltd or Smruthi Organics Ltd?

Market cap of Shilpa Medicare Ltd is 9,643 Cr while Market cap of Smruthi Organics Ltd is 140 Cr

What are the key factors driving the stock performance of Shilpa Medicare Ltd and Smruthi Organics Ltd?

The stock performance of Shilpa Medicare Ltd and Smruthi Organics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Shilpa Medicare Ltd and Smruthi Organics Ltd?

As of June 13, 2025, the Shilpa Medicare Ltd stock price is INR ₹986.15. On the other hand, Smruthi Organics Ltd stock price is INR ₹123.05.

How do dividend payouts of Shilpa Medicare Ltd and Smruthi Organics Ltd compare?

To compare the dividend payouts of Shilpa Medicare Ltd and Smruthi Organics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions